Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ceriani

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Viral Hepatitis|March 16, 2013
Low glomerular filtration rate is a risk factor for ribavirin-associated anaemia in old patients with chronic hepatitis CG Borroni, M Cazzaniga, M Andreoletti, et al.
The American Journal of Gastroenterology|May 26, 2001
Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patientsA Sangiovanni, E Colombo, F Radaelli, et al.
Journal of Endocrinological Investigation|April 11, 2025
Safety of loco-regional treatments in neuroendocrine liver metastases compared to an hepato-cellular carcinoma cohort: a single-center studyB Masoni, S Ferretti, R E Rossi, et al.
Journal of Hepatology|December 2, 1998
HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patientsL Roffi, A Ricci, C Ogliari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2012
Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysisT Pressiani, C Boni, L Rimassa, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Viral Hepatitis|March 16, 2013
Low glomerular filtration rate is a risk factor for ribavirin-associated anaemia in old patients with chronic hepatitis CG Borroni, M Cazzaniga, M Andreoletti, et al.
The American Journal of Gastroenterology|May 26, 2001
Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patientsA Sangiovanni, E Colombo, F Radaelli, et al.
Journal of Endocrinological Investigation|April 11, 2025
Safety of loco-regional treatments in neuroendocrine liver metastases compared to an hepato-cellular carcinoma cohort: a single-center studyB Masoni, S Ferretti, R E Rossi, et al.
Journal of Hepatology|December 2, 1998
HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patientsL Roffi, A Ricci, C Ogliari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2012
Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysisT Pressiani, C Boni, L Rimassa, et al.
Pageof 5